Sify.com » Topics » Nexium
Nexium News
AstraZeneca sues Sun Pharma in us court
Sun had challenged the patent on Nexium IV in the US market. Multinational drug maker AstraZeneca has sued Sun Pharmaceuticals Industries for challenging the patent on its ulcer drug brand, Nexium IV, in the US market. Patent experts said the UK-based drugmaker filed two lawsuits against Sun Pharma and its US subsidiary on February 26 in a federal court in Trenton, New Jersey, and on March 1 in Detroit,
Sun had challenged the patent on Nexium IV in the US market. Multinational drug maker AstraZeneca has sued Sun Pharmaceuticals Industries for challenging the patent on its ulcer drug brand, Nexium IV, in the US market. Patent experts said the UK-based drugmaker filed two lawsuits against Sun Pharma and its US subsidiary on February 26 in a federal court in Trenton, New Jersey, and on March 1 in Detroit,
AstraZeneca makes deal with generic challenger
Britain's AstraZeneca PLC said Thursday it reached a deal with the world's biggest generic drugmaker to delay for three years generic competition to its top-selling drug, the extended-release
Ranbaxy to supply Nexium raw material in Dec-Jan
New Delhi: Ranbaxy Laboratories, India's top drugmaker by sales, will start supplying in December or January a key ingredient to AstraZeneca for anti-ulcer drug Nexium, Ranbaxy CEO Atul Sobti
New Delhi: Ranbaxy Laboratories, India's top drugmaker by sales, will start supplying in December or January a key ingredient to AstraZeneca for anti-ulcer drug Nexium, Ranbaxy CEO Atul Sobti
Dr Reddy's follows Teva on Nexium
In a bid to speed up litigation on blockbuster heartburn drug Nexium (generic esomeprazole) with Anglo-Swedish pharma giant Astra Zeneca, Dr Reddy's Laboratories has field for declaratory judgement on
In a bid to speed up litigation on blockbuster heartburn drug Nexium (generic esomeprazole) with Anglo-Swedish pharma giant Astra Zeneca, Dr Reddy's Laboratories has field for declaratory judgement on
Nexium deal extremely positive: Ranbaxy CEO
Ranbaxy Laboratories, India's top drugmaker by sales, said a patent litigation settlement with AstraZeneca Plc over ulcer pill Nexium was extremely positive and the drug would add to its revenue from
Ranbaxy Laboratories, India's top drugmaker by sales, said a patent litigation settlement with AstraZeneca Plc over ulcer pill Nexium was extremely positive and the drug would add to its revenue from
Ranbaxy receives tentative drug approval from USFDA
The US Food and Drug Administration (USFDA) has granted a tentative approval to Ranbaxy Laboratories Ltd for the manufacturing and marketing of its drug Nexium, popularly prescribed in the treatment o
The US Food and Drug Administration (USFDA) has granted a tentative approval to Ranbaxy Laboratories Ltd for the manufacturing and marketing of its drug Nexium, popularly prescribed in the treatment o
© Copyright Sify Technologies Ltd, 1998-2011. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre.
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise